2. Melanoma proliferation risk assessment device, which includes one or more melanoma (MPMS) oligopoly extracted from a set of selected predictive markers of melanoma (MPMS); procedures for determining patients' melanoma congenital diseases; Procedures for determining whether patients with melanoma are suitable for drug testing

摘要

Kit to determine the risk of Melanoma progression comprising two or more markers of prognosis of melanoma; Device for determining prognosis of melanoma; and Procedure to determineThe prognosis of melanoma in a patient.